请勿错过2012年令人瞩目的活动

2012年8月6日～8日
Westin San Francisco on Market Street
San Francisco, CA 94103

2012年主要的话题

Drug & Diagnostic Development 2012 是能将对疾病生物学特性的理解应用到临床现场，聚焦于因应癌等疾病的新治疗药和引导开发诊断药之抗体医药品开发领域的技术创新、生染色体组相关的实现技术、以及临床生物标记策略等的活动。

Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies
-抗体药物复合体、双重特异性抗体和强化抗体-

• 下一代抗体药物复合体
• 强化抗体和双重特异性抗体

Next-Gen Sequencing Applications & Translational Technologies
-下一代排序的应用和翻译的技术-

• 下一代排序之临床及研究领域的应用
• 转译生物学和翻译技术

The Future of Rx/Dx Summit
-与Rx/Dx的将来有关之高峰会议-

• Rx/Dx（治疗药和陪伴员诊断药）的开发、商品化、合作的模式
• 未来的临床诊断药

Clinical Biomarkers & New Frontiers in Cancer
-癌的临床生物标记与新的研究领域-

• 具临床上意义的生物标记
• 癌的新研究领域：临床研究的新框架

2011 Event Wrap-Up

On top of the perfect weather, attendees enjoyed hearing from the many keynote speakers and taking part in strategic discussion forums, benefiting from the opportunity to toss ideas around with their peers. Everyone from attendees to speakers, sponsors and exhibitors have told us what great contacts they've made at the event. Keep in touch and let us know what you thought by tweeting @drugdisc on twitter.com.

IBC's Drug Discovery & Diagnostic Development 2011 brought together five conference themes in one venue that highlighted emerging strategies and technologies so that you can continue to improve your drug development efforts from target discovery. Focused conference themes included:

• Empowered Antibody Therapies

• Next-Generation Sequencing & Genomic Medicine

• Next-Generation Molecular Diagnostics

• New Frontiers in Cancer

• Targeted Therapeutics